Medication Intervention in Transitional Care to Optimize Outcomes & Costs for CKD & ESRD

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2015

Study Completion Date

April 30, 2016

Conditions
Chronic Kidney DiseaseEnd-Stage Renal Disease
Interventions
OTHER

Medication Information Transfer Intervention

A pharmacist will visit participants randomized to the intervention group in their homes within 5 days of hospital discharge to administer the 5As Medication Self-Management intervention: Assessment, Advise, Agreement, Assistance, Arrangements.

OTHER

Usual care for hospital discharge

Patients will receive medication information according to standard practice for discharge of hospitalized patients.

Trial Locations (1)

99204

Providence Sacred Heart Medical Center & Children's Hospital, Spokane

All Listed Sponsors
collaborator

Washington State University

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Health Sciences & Services Authority of Spokane County

UNKNOWN

collaborator

Providence Sacred Heart Medical Center & Children's Hospital

OTHER

lead

Providence Medical Research Center

OTHER

NCT01459770 - Medication Intervention in Transitional Care to Optimize Outcomes & Costs for CKD & ESRD | Biotech Hunter | Biotech Hunter